Amulet™ ADVANCE LAA

Recruiting in Palo Alto (17 mi)

+28 other locations

Overseen by Dhanunjaya Lakkireddy, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Abbott Medical Devices

No Placebo Group

Trial Summary

What is the purpose of this trial?

This is a prospective, multicenter, observational study intended to characterize real-world outcomes on the commercially available Amulet device in the United States. Over 600 subjects have been enrolled at 16 US clinical sites. Subjects will be followed through 24 months in accordance with each site's standard care practices.

Research Team

Dhanunjaya Lakkireddy, MD

Principal Investigator

Kansas City Cardiac Arrhythmia Research Foundation

Eligibility Criteria

Inclusion Criteria

This is intended for those with the Amulet device who are looking after an older adult.

You are 18 years or older.

You are able and inclined to provide your explicit permission for this clinical research, as well as engage in all related evaluations.

Treatment Details

Who Is Running the Clinical Trial?

Abbott Medical Devices

Lead Sponsor

Trials

659

Recruited

420,000+

Founded

1888

Headquarters

Abbott Park, Illinois, USA

Known For

Medical Devices Innovation

Top Products

FreeStyle Libre, MitraClip, XIENCE Stents, TECNIS IOLs

Dr. Etahn Korngold

Abbott Medical Devices

Chief Medical Officer

Medical training at Harvard Medical School and Massachusetts General Hospital

Robert B. Ford

Abbott Medical Devices

Chief Executive Officer since 2020

Bachelor's degree from Boston College, MBA from UC Berkeley, Haas School of Business